Last reviewed · How we verify
Nicotinamide, ABA and Zinc PCA — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Nicotinamide, ABA and Zinc PCA (Nicotinamide, ABA and Zinc PCA) — Rumah Sakit Pusat Angkatan Darat Gatot Soebroto.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nicotinamide, ABA and Zinc PCA TARGET | Nicotinamide, ABA and Zinc PCA | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nicotinamide, ABA and Zinc PCA CI watch — RSS
- Nicotinamide, ABA and Zinc PCA CI watch — Atom
- Nicotinamide, ABA and Zinc PCA CI watch — JSON
- Nicotinamide, ABA and Zinc PCA alone — RSS
Cite this brief
Drug Landscape (2026). Nicotinamide, ABA and Zinc PCA — Competitive Intelligence Brief. https://druglandscape.com/ci/nicotinamide-aba-and-zinc-pca. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab